Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

BACKGROUND Penicillin-resistant strains of Streptococcus pneumoniae are now found worldwide, and strains with resistance to cephalosporin are being reported. The appropriate antibiotic therapy for pneumococcal pneumonia due to resistant strains remains controversial. METHODS To examine the effect of resistance to penicillin and cephalosporin on mortality, we conducted a 10-year, prospective study in Barcelona of 504 adults with culture-proved pneumococcal pneumonia. RESULTS Among the 504 patients, 145 (29 percent) had penicillin-resistant strains of S. pneumoniae (minimal inhibitory concentration [MIC] of penicillin G, 0.12 to 4.0 micrograms per milliliter), and 31 patients (6 percent) had cephalosporin-resistant strains (MIC of ceftriaxone or cefotaxime, 1.0 to 4.0 micrograms per milliliter). Mortality was 38 percent in patients with penicillin-resistant strains, as compared with 24 percent in patients with penicillin-sensitive strains (P = 0.001). However, after the exclusion of patients with polymicrobial pneumonia and adjustment for other predictors of mortality, the odds ratio for mortality in patients with penicillin-resistant strains was 1.0 (95 percent confidence interval, 0.5 to 1.9; P = 0.84). Among patients treated with penicillin G or ampicillin, the mortality was 25 percent in the 24 with penicillin-resistant strains and 19 percent in the 126 with penicillin-sensitive strains (P = 0.51). Among patients treated with ceftriaxone or cefotaxime, the mortality was 22 percent in the 59 with penicillin-resistant strains and 25 percent in the 127 with penicillin-sensitive strains (P = 0.64) The frequency of resistance to cephalosporin increased from 2 percent in 1984-1988 to 9 percent in 1989-1993 (P = 0.002). Mortality was 26 percent in patients with cephalosporin-resistant S. pneumoniae and 28 percent in patients with susceptible organisms (P = 0.89). Among patients treated with ceftriaxone or cefotaxime, mortality was 22 percent in the 18 with cephalosporin-resistant strains and 24 percent in the 168 with cephalosporin-sensitive organisms (P = 0.64). CONCLUSIONS Current levels of resistance to penicillin and cephalosporin by S. pneumoniae are not associated with increased mortality in patients with pneumococcal pneumonia. Hence, these antibiotics remain the therapy of choice for this disease.

[1]  F. Manresa.  [Resistant pneumococcus]. , 1997, Archivos de bronconeumologia.

[2]  P. Davey,et al.  Growth in the use of antibiotics in the community in England and Scotland in 1980-93 , 1996, BMJ.

[3]  M. Cetron,et al.  The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. , 1995, The New England journal of medicine.

[4]  B. Murray.  Editorial Response: What Can We Do About Vancomycin-Resistant Enterococci? , 1995 .

[5]  P Huovinen,et al.  Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Verhaegen,et al.  Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Kaku,et al.  Trends in antimicrobial resistance of Streptococcus pneumoniae in Japan , 1995, Antimicrobial agents and chemotherapy.

[8]  A. Johnson,et al.  Sensitivity to cefotaxime of pneumococci isolated in the UK. , 1995, The Journal of antimicrobial chemotherapy.

[9]  A. Medeiros,et al.  The growing threat of antibiotic-resistant Streptococcus pneumoniae. , 1995, The Medical clinics of North America.

[10]  Increasing pneumococcal vaccination rates among patients of a National Health-Care Alliance--United States, 1993. , 1995, MMWR. Morbidity and mortality weekly report.

[11]  N. Legakis,et al.  Antibiotic resistance of clinical isolates of Streptococcus pneumoniae in Greece , 1994, Journal of clinical microbiology.

[12]  R. Austrian.  Confronting Drug-resistant Pneumococci , 1994, Annals of Internal Medicine.

[13]  J. Garau,et al.  Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Bates,et al.  Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. , 1994, The Journal of antimicrobial chemotherapy.

[15]  D. Musher,et al.  An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. , 1994, The New England journal of medicine.

[16]  G. Siber.  Pneumococcal disease: prospects for a new generation of vaccines. , 1994, Science.

[17]  F. Tenover,et al.  Emergence of drug-resistant pneumococcal infections in the United States. , 1994, JAMA.

[18]  A. Tomasz,et al.  Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. , 1994, The New England journal of medicine.

[19]  C. John.  Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  F. Baquero,et al.  In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations , 1994, Antimicrobial Agents and Chemotherapy.

[21]  R. Hodes,et al.  Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. , 1994, The New England journal of medicine.

[22]  A. Tomasz,et al.  Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. , 1993, The Journal of infectious diseases.

[23]  G. Caputo,et al.  Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features. , 1993, Archives of internal medicine.

[24]  D. Jarjoura,et al.  Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. , 1993, Chest.

[25]  P. C. Applebaum.  ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS PNEUMONIAE: AN OVERVIEW , 1993 .

[26]  S. Kaplan,et al.  Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. , 1992, Pediatrics.

[27]  B. Spratt,et al.  Genetics of resistance to third‐generation cephalosporins in clinical isolates of Streptococcus pneumoniae , 1992, Molecular microbiology.

[28]  E. Bouza,et al.  Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. , 1992, Archives of internal medicine.

[29]  P. Hopewell,et al.  Pneumococcal Disease during HIV Infection , 1992, Annals of Internal Medicine.

[30]  K. Klugman,et al.  Antibiotic-resistant pneumococcal disease in South African children. , 1992, American journal of diseases of children.

[31]  P. Appelbaum,et al.  Antimicrobial resistance in Streptococcus pneumoniae: an overview. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  J. Pérez,et al.  Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  A. Marton,et al.  Pneumococcal antimicrobial resistance: the problem in Hungary. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  M. Jacobs.  Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  H. Koornhof,et al.  Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  J. Garau,et al.  Penicillin-resistant pneumococci and community-acquired pneumonia , 1992, The Lancet.

[37]  E. Bouza,et al.  Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  J. Dorca,et al.  Needle aspiration techniques in the diagnosis of pneumonia. , 1991, Thorax.

[39]  C. Hoge,et al.  Enterococcal bacteremia: to treat or not to treat, a reappraisal. , 1991, Reviews of infectious diseases.

[40]  A. Tomasz,et al.  Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. , 1991, The Journal of infectious diseases.

[41]  A. Fenoll,et al.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. , 1991, Reviews of infectious diseases.

[42]  F. Baquero,et al.  A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. , 1991, The Journal of antimicrobial chemotherapy.

[43]  K. Klugman.  Pneumococcal resistance to antibiotics , 1990, Clinical Microbiology Reviews.

[44]  D. Gilbert,et al.  Meningitis due to penicillin-resistant Streptococcus pneumoniae in adults. , 1990, Reviews of infectious diseases.

[45]  Leads from the MMWR. Recommendations of the Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine. , 1989, JAMA.

[46]  J. Ariza,et al.  Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. , 1988, The American journal of medicine.

[47]  A. Kendal,et al.  Immunization policies and vaccine coverage among adults. The risk for missed opportunities. , 1988, Annals of internal medicine.

[48]  J. Dorca,et al.  Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. , 1987, The New England journal of medicine.

[49]  B. Rudensky,et al.  Pneumococcal bacteremia--no change in mortality in 30 years: analysis of 104 cases and review of the literature. , 1987, Israel journal of medical sciences.

[50]  A. Tomasz,et al.  Alterations in kinetic properties of penicillin-binding proteins of penicillin-resistant Streptococcus pneumoniae , 1986, Antimicrobial Agents and Chemotherapy.

[51]  C. Feldman,et al.  Community-acquired pneumonia due to penicillin-resistant pneumococci. , 1985, The New England journal of medicine.

[52]  K. Mcintosh,et al.  Selective primary health care: strategies for control of disease in the developing world. XXI. Acute respiratory infections. , 1985, Reviews of infectious diseases.

[53]  I. Phillips,et al.  Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. , 1985, British medical journal.

[54]  A. Geddes,et al.  Pneumococcal bacteraemia--a continuing challenge. , 1984, The Quarterly journal of medicine.

[55]  E. Hook,et al.  Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. , 1983, JAMA.

[56]  M. Freedman,et al.  Pneumococcal Bacteremia in Adults , 1983, Journal of the American Geriatrics Society.

[57]  S. Shapiro.  Case-Control Studies: Design, Conduct, Analysis , 1982 .

[58]  J. Macfarlane,et al.  HOSPITAL STUDY OF ADULT COMMUNITY-ACQUIRED PNEUMONIA , 1982, The Lancet.

[59]  J. Schlesselman,et al.  Case-Control Studies: Design, Conduct, Analysis , 1982 .

[60]  J. Watts,et al.  STREPTOCOCCUS PNEUMONIAE RESISTANT TO PENICILLIN AND CHLORAMPHENICOL IN THE U.K. , 1981, The Lancet.

[61]  S. Berk,et al.  Comparison of community-acquired and nosocomial pneumococcal bacteremia. , 1981, The American review of respiratory disease.

[62]  H. Koornhof,et al.  Antimicrobial Susceptibility Testing of Pneumococci: Determination of Kirby-Bauer Breakpoints for Penicillin G, Erythromycin, Clindamycin, Tetracycline, Chloramphenicol, and Rifampin , 1979, Antimicrobial Agents and Chemotherapy.

[63]  H. Koornhof,et al.  Emergence of multiply resistant pneumococci. , 1978, The New England journal of medicine.

[64]  D. Robinson,et al.  The misuse of antibiotics for treatment of upper respiratory tract infections in children. , 1975, Pediatrics.

[65]  R. Douglas,et al.  Increased resistance to penicillin of pneumococci isolated from man. , 1971, The New England journal of medicine.

[66]  M. Finland,et al.  SUSCEPTIBILITY OF PNEUMOCOCCI TO NINE ANTIBIOTICS , 1965, The American journal of the medical sciences.

[67]  R. Austrian,et al.  PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. , 1964, Annals of internal medicine.

[68]  L. H. Schmidt,et al.  Development of Resistance to Penicillin by Pneumococci , 1943 .

[69]  M. Finland,et al.  CLINICAL SIGNIFICANCE OF BACTEREMIA IN PNEUMOCOCCIC PNEUMONIA , 1937 .